The Effect of Carboxymetyl Starch (Oozfix) on Preventing Postoperative Complication After Gastrectomy
OOZFIX
1 other identifier
interventional
180
1 country
1
Brief Summary
Although the technique of radical gastrectomy had been advanced, postoperative complication can occur in 13\~25% of patient after radical gastrectomy. Pancreatic fistula and postoperative bleeding was reported as 2\~30% and 1\~2%, respectively. These complications often result fatal clinical course, so localized fibrin agent has been widely used at postoperative surgical bed after radical gastrectomy. Recently, natural origin polysaccharide-based carboxymetyl starch was approved as localized coagulative, no well-designed report was adressed in gastric cancer surgery field. This agent can formate physical barrier after application, thus can prevent microbleeding or pancreatic fistula after gastrectomy. THIS study is single-center, non-inferiority, open-label randomized trial that evaluates the effect of carboxymetyl starch (Oozfix) on preventing postoperative complication after gastrectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Oct 2022
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 26, 2022
CompletedFirst Submitted
Initial submission to the registry
November 15, 2022
CompletedFirst Posted
Study publicly available on registry
December 9, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2025
CompletedDecember 9, 2022
December 1, 2022
2.2 years
November 15, 2022
December 8, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Ratio of (patient who suffers from) pancreatic fistula
Ratio of patient who suffers from pancreatic fistula
Postoperative day 3
Study Arms (2)
Oozfix
EXPERIMENTALArm with oozfix after gastrectomy
Greenplast
ACTIVE COMPARATORArm with greenplast after gastrectomy
Interventions
Directly apply carboxymetyl starch (Oozfix) 5 gram evenly at the suprapancreatic surgical bed after gastrectomy
Directly apply Greenplast (Aprotinin 1000kIU/mL, Thrombin 500IU/mL, Fibrinogen 95mg/mL) 4 gram evenly at the suprapancreatic surgical bed after gastrectomy
Eligibility Criteria
You may qualify if:
- Gastric adenocarcinoma patient who underwent radical gastrectomy at Bucheon St. Mary's Hospital
- Patient's Age is above 19 and less than 80
- ECOG performance score : 0\~2
You may not qualify if:
- Patient who underwent emergent gastrectomy
- Patient who requires palliative gastrectomy due to advanced or metastatic carcinoma
- Patient who requires operation due to other malignancy other than adenocrcinoma
- Patient who underwent emergent gastrectomy or pancreatectomy before this study
- Patient who underwent chemoradiation
- Patient who took anticoagulants or with coagulopathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
BucheonStMarys
Bucheon-si, South Korea
Related Publications (1)
Washio M, Yamashita K, Niihara M, Hosoda K, Hiki N. Postoperative pancreatic fistula after gastrectomy for gastric cancer. Ann Gastroenterol Surg. 2020 Sep 21;4(6):618-627. doi: 10.1002/ags3.12398. eCollection 2020 Nov.
PMID: 33319151BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Hayemin LEE
Bucheon St. Mary's Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 15, 2022
First Posted
December 9, 2022
Study Start
October 26, 2022
Primary Completion
December 31, 2024
Study Completion
January 31, 2025
Last Updated
December 9, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share